AAP
ALT icon

Arax Advisory Partners’s Altimmune ALT Stock Holding History

Arax Advisory Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Sell
339
-7,826
-96% -$33.2K ﹤0.01% 3290
2025
Q4 		$29.5K Buy
8,165
+4,076
+100% +$17.8K ﹤0.01% 1906
2025
Q3 		$15.4K Buy
4,089
+2,447
+149% +$9.45K ﹤0.01% 2391
2025
Q2 		$6.35K Buy
1,642
+1,028
+167% +$5.56K ﹤0.01% 2150
2025
Q1 		$3.07K Sell
614
-111
-15% -$703 ﹤0.01% 1950
2024
Q4 		$5.23K Buy
725
+592
+445% +$4.52K ﹤0.01% 1727
2024
Q3 		$817 Hold
133
– – ﹤0.01% 2316
2024
Q2 		$885 Buy
+133
New +$981 ﹤0.01% 2205

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Arax Advisory Partners's ALT Position: Q1 2026 in Review

Arax Advisory Partners reduced its Altimmune (ALT) stake by 96% in Q1 2026, selling an estimated $33.2K and leaving 339 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Arax Advisory Partners first reported a position in ALT in Q2 2024 and has held it in 8 quarters since. The position peaked at $29.5K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Arax Advisory Partners held 339 shares of Altimmune worth $1.04K as of Q1 2026.
  • Arax Advisory Partners sold 7,826 Altimmune shares in Q1 2026, an estimated $33.2K.
  • Altimmune made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3290 holding.
  • Arax Advisory Partners first reported a position in Altimmune in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Altimmune position peaked at $29.5K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.